• 1. A highly selective on–off–on responsive lanthanide(iii) based probe for recognition of copper and hydrogen sulfide
  Yuk-Wang Yip,Ga-Lai Law,Wing-Tak Wong Dalton Trans. 2016 45 928

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives

Recent Advances in the Application of (4-Bromopyridin-2-yl)methanol (CAS: 131747-45-0) in Chemical Biology and Pharmaceutical Research

(4-Bromopyridin-2-yl)methanol (CAS: 131747-45-0) is a key intermediate in the synthesis of various bioactive molecules and pharmaceuticals. Recent studies have highlighted its versatility in medicinal chemistry, particularly in the development of kinase inhibitors, antiviral agents, and other therapeutic compounds. This research brief consolidates the latest findings on the applications, synthetic pathways, and biological activities associated with this compound.

One of the most significant advancements involves the use of (4-Bromopyridin-2-yl)methanol as a building block for the synthesis of novel kinase inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in the development of selective JAK2 inhibitors, which show promise for treating myeloproliferative neoplasms. The compound's bromine moiety allows for further functionalization via cross-coupling reactions, enabling the creation of diverse pharmacophores.

In the realm of antiviral research, (4-Bromopyridin-2-yl)methanol has been employed in the synthesis of potential SARS-CoV-2 main protease inhibitors. A recent preprint on bioRxiv detailed its incorporation into a series of peptidomimetic compounds that exhibit nanomolar inhibitory activity against the viral protease. The hydroxyl group of the molecule serves as a crucial point for conjugation with other pharmacologically active fragments.

The compound's role in PET tracer development has also gained attention. Researchers at the University of California reported in Nuclear Medicine and Biology the use of (4-Bromopyridin-2-yl)methanol as a precursor for 18F-labeled pyridine derivatives. These tracers show excellent blood-brain barrier penetration and are being evaluated for imaging neurodegenerative diseases.

From a synthetic chemistry perspective, recent work published in Organic Letters has optimized the preparation of (4-Bromopyridin-2-yl)methanol through catalytic C-H functionalization, achieving higher yields and better atom economy compared to traditional methods. This advancement is particularly important for scaling up production for pharmaceutical applications.

Ongoing research is exploring the compound's potential in targeted drug delivery systems. A 2024 study in Advanced Drug Delivery Reviews highlighted its use in constructing pH-sensitive drug conjugates, where the pyridine moiety acts as both a targeting group and a release trigger in acidic tumor microenvironments.

In conclusion, (4-Bromopyridin-2-yl)methanol (131747-45-0) continues to be a valuable scaffold in pharmaceutical research, with emerging applications across multiple therapeutic areas. Its synthetic versatility and ability to serve as a precursor for diverse bioactive molecules make it a compound of significant interest in current chemical biology research.

• 31181-82-5(2-Pyridinemethanol,5-bromo-, hydrochloride (1:1))
• 773871-93-5((4-Bromo-1H-pyrrol-2-yl)methanol)
• 820224-83-7((4-Bromo-5-methylpyridin-2-yl)methanol)
• 88139-91-7(5-Bromo-2-hydroxymethylpyridine)
• 120491-88-5((4-Bromopyridine-2,6-diyl)dimethanol)
• 30766-03-1(4-Bromopicolinic acid)
• 6329-89-1(2-Pyridinemethanol,hydrochloride (1:1))
• 33434-94-5(Pyridinemethanol)
• 586-98-1(2-Pyridinemethanol)
• 448906-60-3((4-Bromo-6-methylpyridin-2-YL)methanol)